FEATURED NEWS

• HDA Statement on 60 Minutes/Washington Post Coverage on Distributors, Opioid Epidemic

  October 13, 2017

  HDA President and CEO John M. Gray released the following statement in response to 60 Minutes/Washington Post coverage on the opioid epidemic.

• Giacomin, Smith Reelected to Lead HDA Board of Directors

  September 26, 2017

  The Healthcare Distribution Alliance (HDA) announced Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, will serve a second term as Chairman of the HDA Board of Directors. Mr. Giacomin’s reelection was announced at the HDA Annual Board and Membership Meeting. Henry Dale Smith, Jr., Chairman and CEO, H. D. Smith Holding Company, also was reelected to serve as Vice Chairman.

• HDA Statement on Attorneys General Opioid Investigation

  September 19, 2017

  Following today’s announcement on investigations regarding the opioid epidemic, John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), released the following statement.

• Prescribing Patterns and the Opioid Epidemic

  September 7, 2017

  While the factors driving the opioid epidemic are complex, there is broad recognition among leading public health authorities that opioids have been overprescribed — a trend that began in the 1990s and continues to this day. As the broader healthcare industry looks to reverse and prevent another epidemic in the future, there is greater focus on how to effectively curb overprescribing while balancing the legitimate and diverse health needs of patients across the country.

• HDA "Origin" Repository Officially Launches

  July 31, 2017

  The Healthcare Distribution Alliance (HDA), in collaboration with ValueCentric, LLC, today announce the official launch of Origin: HDA’s Product Data Source. Origin is a high-powered, central data repository hosting verified Global Trade Item Number (GTIN) information. The service enables the secure, accurate and efficient exchange of pharmaceutical product master data between manufacturers and their supply chain partners to help comply with the Drug Supply Chain Security Act (DSCSA).